CA21154 - Translational control in Cancer European Network (TRANSLACORE)
TRANSLACORE
Understanding the importance of protein synthesis dysregulation in cancer
CA21154 - Translational control in Cancer European Network (TRANSLACORE)
Translacore
Join the Network
CA21154 - Translational control in Cancer European Network (TRANSLACORE)
Map of TRANSLACORE Team Members Across Europe
Our aims
Philosophy
Understanding the importance of protein synthesis dysregulation in cancer
Objectives
Promoting multiple cross-disciplinary research partnerships
Capacity Building
Strengthen scientific interactions among experts across Europe with complementary skills
State of the art
Dysregulated translation in cancer exposes vulnerabilities that are amenable to targeted therapies.
People involved in Translacore
View all members
You might also like
Translacore open database
Post-Doctoral Position in the field of Translational Control in Cancer
Post-doctoral Position for a full-time position at the Biffo’s lab, at the National Institute of Genetics (www.ingm.org)
Grant for a Short-Term Scientific Mission
As the 4th year of TRANSLACORE has now started, we are pleased to launch the 1st Call of Short-Term Scientific Mission (STSM).
Diet boosts drug effect against neuroblastoma
A new Nature study by member of the TRANSLACORE society - Raphael J. Morscher and colleagues reveals that combining a specific diet with the drug difluoromethylornithine can significantly slow neuroblastoma growth. By restricting the amino acids arginine and proline, researchers reduced polyamine production, molecules that fuel tumour growth. This dual approach disrupted cancer protein synthesis, and improved survival. The findings highlight how diet can be harnessed to reprogram aggressive childhood cancers toward remission.
